05/25/22 4:43 PMNYSE : IQV conferencesIQVIA CFO Ron Bruehlman to Speak at Jefferies Healthcare Conference on June 10, 2022IQVIA Holdings Inc., announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Jefferies Healthcare Conference in New York City on Friday, June 10, 2022 at 11:30 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com.RHEA-AIneutral
04/27/22 7:00 AMNYSE : IQV IQVIA Reports First-Quarter 2022 ResultsIQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2022. R&DS contracted backlog, including reimbursed expenses, grew 9.1 percent year-over-year to $25.3 billion as of March 31, 2022.RHEA-AIneutral
04/21/22 8:00 AMNYSE : IQV covid-19Spending on U.S. Medicines Rose 12% in 2021 Due to COVID-19 Vaccines and Therapies, Says IQVIA Institute for Human Data ScienceSpending on medicines in the United States, at estimated net manufacturer prices, reached $407 billion in 2021, up 12% over 2020, as COVID-19 vaccines and therapeutics became widely available and added $29 billion in related spending. That’ s according to a new U.S. Medicines Trends 2022 Report, released today by the IQVIA Institute for Human Data Science.RHEA-AIneutral
04/12/22 4:15 PMNYSE : IQV IQVIA to Announce First-Quarter 2022 Results on April 27, 2022IQVIA Holdings Inc. will announce its first-quarter 2022 financial results before the market opens on Wednesday, April 27, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the...RHEA-AIneutral
03/30/22 6:00 PMNYSE : IQV IQVIA Selected to Support EMA’s DARWIN EU® Coordination Centre InitiativeIQVIA™, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that the European Medicines Agency has awarded a contract to Erasmus University Medical Center Rotterdam to provide analytics services to the DARWIN EU ® Coordination Centre which IQVIA was...RHEA-AIneutral
03/15/22 6:05 PMNYSE : IQV IQVIA Launches OCE+ To Deliver Enhanced AI-Driven Customer EngagementIQVIA™ today announced the launch of OCE+, the first of several new advancements to its leading life science customer engagement platform. OCE+ adds IQVIA’ s Next Best recommendation engine– a daily workflow tool providing AI-driven recommendations for engaging healthcare professionals– to its Orchestrated Customer Engagement platform, providing enhanced...RHEA-AIvery positive
03/14/22 9:00 AMNYSE : IQV managementIQVIA Appoints Costa Panagos President of Research & Development Solutions (R&DS)IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and contract services to the life sciences industry, today announced the appointment of Costa Panagos, to serve as president of its Research& Development Solutions business unit. Mr. Staub will remain with the company as a senior advisor to the CEO and continue...RHEA-AIneutral
03/03/22 4:15 PMNYSE : IQV conferencesIQVIA CFO to Speak at Barclays Global Healthcare Conference on March 16, 2022IQVIA Holdings Inc., announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays Global Healthcare Conference in Miami, FL on Wednesday, March 16, 2022 at 1:35 p.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com.RHEA-AIneutral
03/01/22 8:00 AMNYSE : IQV clinical trialIQVIA selected to accelerate clinical development of VYVGART™ (efgartigimod alfa fcab) by argenx SEIQVIA announced an agreement today with argenx SE. “We are excited to be working with argenx in a comprehensive way to support the development of their promising new treatment,” said Alistair Grenfell, president, Europe, Middle East, Africa and South Asia for IQVIA.“ IQVIA’ s end-to-end support will speed the clinical development and the commercial launch of new...RHEA-AIvery positive
02/24/22 8:00 AMNYSE : IQV IQVIA Named Top CRO in 2021 WCG CenterWatch Independent SurveyIQVIA™, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry was named the top CRO in Overall Reputation by clinical trial sites around the world in the 2021 WCG CenterWatch Global Site Relationship Benchmark Survey Report. The results were based on responses from investigators,...RHEA-AIneutral